Summary
Introduction
Unlike other dietary amino acids, those with branched chains, leucine, isoleucine and valine, are metabolized initially in muscle and in other peripheral tissues, rather than in the liver (Miller, 1962;  McMenamy, Shoemaker, Richmond & Elwyn, 1962) . After a protein meal these amino acids comprise between 60-90% of the aminonitrogen taken up by the muscle (Wahren, Felig & Hagenfeldt, 1976) . In the rat, this preferential muscle metabolism of branched-chain amino acids is brought about by a branched-chain amino acid aminotransferase, which is more abundant in muscle than in liver (Ichihara & Koyama, 1967; Shinnick & Harper, 1976) . This distribution may allow these essential dietary amino acids to reach the peripheral tissues (Krebs, 1972) .
The circulating concentration of leucine usually parallels that of the total branched-chain amino acids; it is increased by starvation (Felig, Owen, Wahren & Cahill, 1969) , surgery (Dale, Young, Latner, Goode, Tweedle & Johnston, 1977) , accidental injury (Wedge, De Campos, Kerr, Smith, Farrell, Ilic & Williamson, 1976 Woolf, Moore, Groves & Duff, 1979) and diabetes mellitus (Felig, Marliss, Ohman & Cahill, 1970;  Berger, Zimmermann-Telschow, Berchtold, Drost, Muller, Gries & Zimmermann, 1978) ; it is decreased in patients with insulinomas (Berger et al., 1978) and liver disease (Fischer, Yoshimura, Aguire, James, Cummings, Abel & Deindorfer, 1974;  Ansley, Isaacs, Rikkers, Kutner, Nordlinger & Rudman, 1978) .
A key question in investigating these changes is whether they are primarily due to alterations in production or removal of this amino acid by the tissues. Sherwin and his colleagues (Sherwin, 1978; Gelfand, Hendler & Sherwin, 1979) showed that in normal subjects both carbohydrate restriction and starvation decreased the removal rate of exogenous leucine (given parenterally or as oral protein); and our preliminary studies suggested that after total hip replacement a protein meal produces the largest increment in blood branched-chain amino acids in the early postoperative days (Elia, Smith & Williamson, 1979) . Such findings indicated that surgery might interfere with the removal of branched-chain amino acids by peripheral tissues, but they did not exclude the effect of temporary restriction of energy or carbohydrate. We have now examined this problem further by measuring the basal blood concentration of leucine and the removal rate of an intravenous load in orthopaedic surgery patients maintained on a virtually constant diet, except for the day of operation, and compared the results with those of accidental injury, starvation, insulin-dependent diabetes, cirrhosis and muscular dystrophy. Further, since the raised blood concentration of leucine of starved or carbohydrate-restricted subjects and patients with diabetes is associated with increased concentrations of ketone bodies and plasma nonesterified fatty acids, we have produced these changes in normal subjects by the infusion of the fat emulsion Intralipid, and measured the effect on leucine removal.
Methods

Patients
The subjects (Table 1) include those in our previous study of alanine metabolism (Elia, Ilic, Bacon, Williamson 8c Smith, 1980) , which gives details of energy and protein intake in the total hip replacement group. Except on the day of operation these patients received a diet containing 0.126-0.146 MJ and 1.2-1.4 g of protein day-l kg-' body wt. An intravenous leucine load was given (see below) before operation and on the fourth (day +4) and eighth (day +8) day after surgery. The accidentally injured subjects had the same intake as the surgical patients on day + 3 and 4, and had a leucine infusion on day +4. Patients with muscular dystrophy and cirrhosis were on a normal diet, and those with diabetes (juvenile-onset insulin-dependent) on a variable carbohydrate diet.
Four healthy subjects (Table 1) were starved completely for 4 days. They were infused with leucine on the day before starvation began (day 0), on day +4 and after 24 h of refeeding (day +5). Three subjects (including two of those who were starved) were infused twice with leucine; on one occasion 20% Intralipid was also infused at a rate of 1 ml/min for 250 min and the metabolic effects and removal of leucine were measured in the last 70 min.
The study was approved by the local Ethics Committee and the subjects gave informed consent.
Procedure
Blood (2 ml) from the antecubital vein of overnight fasted, resting subjects was immediately deproteinized with 5 ml of 10% perchloric acid and then neutralized. Glucose, ketone bodies, pyruvate and lactate were analysed by methods previously described (Elia, Oppenheim, Smith, Ilic & Williamson, 1979) . The concentrations of The increments in leucine concentration between 20 and 70 min (approximately 800 and 250 pnolll respectively) were plotted on sbmilogarithmic paper and the half-life (to5) was estimated. The distribution volume and the clearance rate/kg body wt. were calculated as described for alanine (Elia et al., 1980) .
For the purpose of statistical analysis the initial measurements on the six surgical and four starvation subjects were combined to form a 'normal' group. Student's t-test has been used for comparison between groups. Where appropriate, as in the consecutive studies on the same group of individuals during starvation and surgery, a paired t-test has been applied.
Results
Basal blood concentration of leucine
During starvation (Fig. 1) the basal concentration of leucine doubled to reach a plateau and returned to normal after 24 h of refeedhg. After total hip replacement the basal concentration of leucine also showed a temporary increase ( Fig. 2 and Table 2), the energy and protein intake remained nearly constant, and the urine nitrogen increased (Fig. 3) .
After accidental injury the leucine concentration (measured only on day +4) was higher than after elective surgery. In the patients with cirrhosis, the mean basal concentration of leucine was significantly lower than in the 10 normal control subjects (Table 3) . It was not significantly abnormal in patients with diabetes or muscular dystrophy.
Intralipid infusion, which produced an acute elevation of circulating ketone bodies, and presumably of non-esteded fatty acids, had no effect on the basal concentration of leucine (Table   800   i 
Removal of the intravenous leucine load
Starvation doubled the fo.5 and decreased the clearance rate of infused leucine; these changes were reversed by 24 h of refeeding ( Table 2) . In contrast, surgery did not significantly alter the to.5 but on day +4 the clearance rate was significantly increased ( Table 2) . After severe accidental injury, the removal of the leucine load was significantly more rapid than in the control subjects.
Intralipid infusion did not produce any significant change in f,,.5 or clearance rate of leucine. In the diabetic patients the leucine load was removed significantly more slowly than normal. In cirrhosis and muscular dystrophy the clearance rates of leucine were significantly abnormal whereas the mean values for to.5 were normal. The discrepancies sometimes found between fo.5 and clearance rate were accounted for by variations in the distribution volume of leucine (Table 3) .
Biochemical effects of leucine infusion
Intravenous leucine produced a decrease in blood glucose in the normal subjects, in those after surgery and accidental injury and in those with muscular dystrophy. However, leucine produced no change in blood glucose when infused on day +4 of starvation, even though a significant decrease was observed before and after starvation in the same subjects (Fig. 4) . In contrast leucine produced an increase in blood glucose in the cirrhotic and diabetic patients, which was significant in the cirrhotic subjects only at +30 and +40 min. In all patients leucine infusion increased ketonebody concentrations (Fig. 5) . In infusion. In the diabetic (W, n = 4) and Intralipid (A, n = 3) groups the basal concentration was elevated (normal < 0.2 mmol/l) and in the normal (0, n = 10) group it was rising slowly at 0 min (see the Results section). After leucine infusion the ketone-body concentration increased by about 0.05 mmol/l in the normal group and by more than 0.5 mmol/l in the other two groups. dystrophy, this increase was slight (approximately 0.05 mmol/l). In contrast, in the diabetic patients and in those infused with Intralipid, who had elevated basal ketone-body concentrations of TABLE 4. Changes in blood amino acid concentrations before and after a leucine infusion in ten normal subjects your prestarvation and six preoperative subjects)
Values in mmol/l are means 1 SEM. Leucine (3.8 g) was infused between 0 and + 10 min. Significance of differences apply to measurements made on at least nine patients: *P < 0.05; **P < 0.025; ***P < 0.01. In postabsorptive normal subjects the changes in amino acids produced by leucine infusion were not marked (Table 4) . However, there was a significant increase in glutamine for 1 h after leucine infusion and significant decreases in valine, phenylalanine, alanine, tyrosine and isoleucine. The initial temporary increase in isoleucine concentration was attributable to contamination of the infused leucine with 2-2.59s of isoleucine. Amino acid analysis of the leucine preparation did not demonstrate any other contaminants.
Time (min)
The short infusions of leucine did not appear to produce any effect on the postoperative nitrogen balance.
Discussion
Metabolism of leucine
The disappearance of an infused leucine load is thought to depend mainly on its uptake and oxidation in muscle cells (Fig. 6) . Protein synthesis may contribute, but where leucine is given without other amino acids this is probably of minor importance. For its initiai metabolism leucine is converted into ketoleucine ( Fig. 6 ; step 1) by the action of branched-chain amino acid aminotransferase (EC 2.6.1.42), an enzyme whose total activity is greater in muscle than in any other tissue. Ketoleucine is then metabolized further in muscle or transferred to the liver [ Fig. 6 , broken line; Shinnick & Harper, 1976; Krebs & Lund, 1977; Livesey & Lund, 19801 . Acetyl-CoA derived from ketoleucine may be oxidized to carbon dioxide, but in the liver it can also be converted into lipids (Ramsey, 1976) or released as ketone bodies (Krebs & Lund, 1977) (Fig. 6 ).
Basal concentration of leucine
The increase in blood concentration of leucine after 4 days of complete starvation was considerably greater than after surgery. The increased concentrations of ketone bodies and non-esteriiied fatty acids which accompanies starvation might account for this difference. A high-fat diet (2-6 days) is known to specifically increase the branched-chain amino acid concentrations (Swendseid, Yamoda, Vinyard, Figueroa & Drenick, 1967) . However, the infusion of Intralipid, which produced an acute elevation of blood ketone bodies (to about 0.5 mmol/l), and presumably also of non-esterified fatty acids (Elkeles, Chalmers & Hambley, 1978) and triacylglycerol, did not significantly alter the basal concentration of leucine.
Since the orthopaedic surgery patients were on a constant diet, the observed increase in leucine cannot be attributed to starvation, and was most likely to have resulted from net protein breakdown as indicated by the negative nitrogen FIG. 6. Hepatic and muscle metabolism of a leucine load. Although some leucine may be incorporated into protein, the majority is deaminated to ketoleucine by branched-chain amino acid aminotransferase (1). The conversion of ketoleucine into acetyl-CoA (AcCoA) and acetoacetate (AcAc) is initiated by branched-chain crketo acid dehydrogenase (2). AcCoA is oxidized to carbon dioxide in the Krebs cycle; in the liver, it may be additionally converted into ketone bodies and lipids. The likely major pathway of leucine metabolism is indicated by -, and the possible transfer of ketoleucine from muscle to liver by ---. The relative importance of tissues such as adipose and nervous tissue in leucine and ketoleucine metabolism has still to be defined.
balance. The same reasoning applies after severe accidental injury. This conclusion fits in with the observation that the post-injury increase in circulating branched-chain amino acids is greatest in patients with the largest loss of nitrogen (Wedge el al., 1976), and with the demonstration by Aulick 8c Wilmore (1979), using arteriovenous femoral differences, that burned patients released increased amounts of leucine (and other amino acids) from their peripheral tissues.
In patients with diabetes the branched-chain amino acid concentrations are selectively increased (Felig et al., 1970; Berger et al., 1978) and our results are compatible with this, although the increase in basal leucine was not significantly greater than normal. The amount of leucine is very sensitive to insulin concentration (Fischer el al., 1974) , and an elevated plasma concentration of insulin may account for the low amounts of leucine in cirrhosis (Munro, Fernstrom & Wurtman, 1975; James, Jeppsson, Ziparo & Fischer, 1979) . Since leucine is initially dealt with in muscle we thought that its metabolism might be abnormal in muscular dystrophy. However, this is not suggested by its circulating concentration, which is normal (Bank, Rowland 8c Ipsen, 1971; Haymond, Strobe1 8c De Vivo, 1978) , but by its clearance rate, which is decreased (see below).
Removal of intravenous leucine
The removal of intravenous leucine was measured from an estimation of its half-life (tW3), and from a calculated clearance rate which takes into account the apparent distribution volume of the injected leucine. This volume (per kg body wt.) is larger than the extracellular space, and must include part of the intracellular space. Since there is often fluid retention after surgery, injury and cirrhosis, a temporary increase in distribution volume in these patients is not unexpected; but the apparent increase in distribution volume on day 4 of starvation, when the extracellular space is probably less than normal, is inexplicable.
The most clear-cut change was the delayed removal of a leucine load given during starvation, with rapid reversal on refeeding. Sherwin (1978) used 12 h leucine infusions and found that the estimated metabolic clearance rate of leucine fell by 48% after 3 days fasting. Since in our patients, like those of Sherwin (1978) , the period of starvation was short, the delay in removal cannot be attributed to a significant reduction in muscle mass. Our results of leucine removal apparently conflict with animal studies which indicate that during starvation the oxidation of labelled leucine in uiuo (Sketcher, Fern & James, 1974) and in uitro (Goldberg & Odessey, 1972; Paul & Adibi, 1976 ) is increased. The reason for this is not clear.
In contrast, orthopaedic surgery produced no significant change in the but the clearance rate was increased on the fourth postoperative day; the removal of leucine after accidental injury was accelerated. It is possible that on day +4 the increased clearance of leucine in these two groups of patients is related to increased perfusion of muscle.
Although it is unwise to extrapolate from the results of leucine loading to the changes in basal leucine, the present evidence suggests that the increase in basal leucine produced by starvation is associated with its decreased clearance, whereas that after surgery or accidental injury is largely due to a net increase in protein breakdown.
In our diabetic patients the significant delay in removal of the leucine load agrees with the observations of Sherwin, Rosenzweig, Soman, Hendler & Felig (1976) . Acute elevation of the blood concentrations of ketone bodies and nonesterified fatty acids (with Intralipid) do not reproduce to any extent the effect of diabetes or starvation on leucine removal. The precise effect of insulin on leucine metabolism is unknown, but insulin may stimulate leucine uptake across the cell membrane and increase protein synthesis (Pozefsky, Felig, Tobin, Soeldner & Cahill, 1969; Jefferson, Rannels, Munger & Morgan, 1974) .
In those patients with cirrhosis and muscular dystrophy the results are difficult to assess because of the few patients studied. The increased clearance rate of leucine in cirrhotic patients does, however, agree with the results of others, who gave either an oral or an intravenous mixture of amino acids (Iob, Coon & Sloan, 1966) or oral casein (Richmond & Girdwood, 1962) .
In the dystrophic patients the apparent delay in metabolic clearance rate of leucine could merely reflect a reduction in the amount of muscle, irrespective of changes in its metabolism.
Biochemical effects of infused leucine
In our surgical patients and in subjects before and after starvation, leucine produced a fall in blood glucose, attributable to an increased secretion of insulin, and also to direct inhibition of hepatic gluconeogenesis (as observed in liver slices by Greenberg & Reaven, 1966) . In the insulin-dependent patients with diabetes the glucose concentration increased by 0.6 mmol/l after leucine; but it is difficult to know whether this change is spontaneous. The cause of the increase in blood glucose after leucine in the cirrhotic patients is unknown.
In all groups of patients the ketone-body concentration increased after leucine was given; and in the patients with diabetes and subjects infused with Intralipid the increase was 10-fold that of normal subjects (Fig. 5) . This change may be partly spontaneous, partly due to the increased ketone-body production from leucine and ketoleucine in the liver and partly due to the interference with ketone-body uptake by acetoacetate formed from leucine in muscle (Fig. 5) . The concentration of ketone bodies in the circulation will itself be affected by the prevailing insulin concentration.
The changes in amino acids were less marked than those induced by prolonged low-dose infusions in fasting subjects by Sherwin (1978) . However, the significant decrease in blood phenylalanine, valine and other amino acids caused by leucine infusion is compatible with its effect in stimulating protein synthesis; the increase in glutamine, but not alanine, after leucine, agrees with measurements of forearm arteriovenous differences in resting subjects given a leucine meal (G. F. Cahill, personal communication) .
In conclusion, our results indicated that leucine metabolism in man is affected in different ways by different stresses and that the effects of surgery upon it are not the same as those of starvation. We have confirmed Sherwin's (1978) observation that removal of leucine is decreased in starvation and have also shown that this can be rapidly reversed on refeeding; our experiments with Intralipid further suggest that, at least in the short term, increases in ketone bodies or non-esterified fatty acids are not the cause for this decreased removal.
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